![Rohit Mehta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Rohit Mehta first degree
Entity | Entity type | Industry | |
---|---|---|---|
Biothea Pharma, Inc.
![]() Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rohit Mehta via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
ATHENEXPAR | Pharmaceuticals: Major | Director/Board Member | |
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Founder | |
ALZHEON, INC. | Biotechnology | Director/Board Member | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Arctic Funds Plc - Aurora LifeScience | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
William Blair & Co. LLC
![]() William Blair & Co. LLC Regional BanksFinance William Blair & Co. LLC (William Blair) is a SEC-registered broker/dealer firm headquartered in Chicago, Illinois. The firm was founded by William McCormick Blair in 1935 and is a subsidiary of WBC Holdings LP. Until 1941, they were known as Blair, Bonner & Co. William Blair provides broking services to individual, institutional and issuing clients. | Regional Banks | Corporate Officer/Principal | |
ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer | |
Vector Securities LLC
![]() Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Investment Banks/Brokers | Corporate Officer/Principal | |
OREXO AB | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Chicago | College/University | Graduate Degree | |
Karolinska Development AB (Private Equity)
![]() Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer | |
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
University of Aarhus | College/University | Doctorate Degree | |
Biolipox AB
![]() Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
University of Marseille | College/University | Doctorate Degree | |
Medical College of Virginia | College/University | Corporate Officer/Principal | |
TALPHERA, INC. | Pharmaceuticals: Major | Director/Board Member | |
The University of Alabama at Birmingham | College/University | Corporate Officer/Principal | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Pergamum AB
![]() Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
NEOS AB | Medical Specialties | Chairman | |
Action Pharma Holding I A/S | Director/Board Member | ||
TBIOTECH ApS | Corporate Officer/Principal | ||
Palette Life Sciences AB
![]() Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
The BioExec Institute, Inc.
![]() The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Axela AB | Director/Board Member | ||
KDev Investments AB
![]() KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Chairman | |
Arctic Asset Management AS (Sweden)
![]() Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | Investment Managers | Founder | |
OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SH Parent, Inc.
![]() SH Parent, Inc. Financial ConglomeratesFinance SH Parent, Inc. operates as a development stage company. The company is headquartered in Atlanta, GA. | Financial Conglomerates | Director/Board Member | |
Pegaone GmbH
![]() Pegaone GmbH Information Technology ServicesTechnology Services Pegaone GmbH is a services and German solutions company that specializes in helping businesses transform and evolve digitally. The private company is based in Regensburg, Germany. The company achieves this by executing Pega implementations through proactive collaboration with their customers. | Information Technology Services | Chairman | |
ABG ACQUISITION CORP. I | Financial Conglomerates | Director/Board Member | |
TXP Pharma AG (Switzerland)
![]() TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Pharmaceuticals: Major | Chairman | |
TXP Pharma GmbH | Founder |
Statistics
International
United States | 25 |
Sweden | 14 |
Denmark | 8 |
France | 3 |
Germany | 3 |
Sectoral
Health Technology | 23 |
Finance | 12 |
Consumer Services | 7 |
Commercial Services | 4 |
Miscellaneous | 3 |
Operational
Director/Board Member | 24 |
Corporate Officer/Principal | 13 |
Chairman | 10 |
Chief Executive Officer | 8 |
Founder | 6 |
Most connected contacts
Insiders | |
---|---|
Torbjørn Bjerke | 27 |
Jean-Pierre Sommadossi | 17 |
Marina Bozilenko | 13 |
- Stock Market
- Insiders
- Rohit Mehta
- Company connections